$SSKN
STRATA Skin Sciences, Inc.

2024 Q3 Form 10-Q Financial Statement

#000114036124037362 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $8.797M $8.435M
YoY Change -0.62% 2.24%
Cost Of Revenue $3.490M $3.498M
YoY Change -10.47% -11.04%
Gross Profit $5.307M $4.937M
YoY Change 7.13% 14.34%
Gross Profit Margin 60.33% 58.53%
Selling, General & Admin $6.717M $5.224M
YoY Change 26.24% -11.55%
% of Gross Profit 126.57% 105.81%
Research & Development $243.0K $199.0K
YoY Change -2.02% -46.79%
% of Gross Profit 4.58% 4.03%
Depreciation & Amortization $1.239M $1.250M
YoY Change -14.49% -12.46%
% of Gross Profit 23.35% 25.32%
Operating Expenses $6.960M $5.423M
YoY Change 24.98% -13.65%
Operating Profit -$1.653M -$486.0K
YoY Change 168.78% -75.23%
Interest Expense -$469.0K -$477.0K
YoY Change -188.83% -260.07%
% of Operating Profit
Other Income/Expense, Net -$469.0K $387.0K
YoY Change 7.08% -132.63%
Pretax Income -$2.122M -$99.00K
YoY Change 101.52% -96.86%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.122M -$99.00K
YoY Change 101.52% -96.86%
Net Earnings / Revenue -24.12% -1.17%
Basic Earnings Per Share -$0.53 -$0.03
Diluted Earnings Per Share -$0.53 -$0.03
COMMON SHARES
Basic Shares Outstanding 4.171M 35.06M
Diluted Shares Outstanding 4.039M 3.506M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.062M $5.483M
YoY Change -0.97% -39.31%
Cash & Equivalents $7.062M $5.483M
Short-Term Investments
Other Short-Term Assets $1.631M $1.671M
YoY Change -1.98% -11.54%
Inventory $2.744M $2.692M
Prepaid Expenses
Receivables $4.443M $3.979M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.88M $13.83M
YoY Change -19.48% -34.93%
LONG-TERM ASSETS
Property, Plant & Equipment $10.39M $11.15M
YoY Change 25.81% 34.02%
Goodwill $6.519M $6.519M
YoY Change -25.95% -25.95%
Intangibles $5.840M $6.334M
YoY Change -39.31% -60.31%
Long-Term Investments
YoY Change
Other Assets $231.0K $325.0K
YoY Change 225.35% 357.75%
Total Long-Term Assets $24.33M $25.76M
YoY Change -11.45% -24.16%
TOTAL ASSETS
Total Short-Term Assets $15.88M $13.83M
Total Long-Term Assets $24.33M $25.76M
Total Assets $40.21M $39.58M
YoY Change -14.81% -28.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.749M $2.886M
YoY Change -44.6% -25.62%
Accrued Expenses $8.524M $6.608M
YoY Change 44.45% -1.83%
Deferred Revenue $2.421M $2.261M
YoY Change 1.51% -7.18%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.05M $12.13M
YoY Change 16.81% -14.07%
LONG-TERM LIABILITIES
Long-Term Debt $15.15M $15.11M
YoY Change 0.91% 0.85%
Other Long-Term Liabilities $1.477M $2.652M
YoY Change -59.57% -70.14%
Total Long-Term Liabilities $15.15M $15.11M
YoY Change 0.91% 0.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.05M $12.13M
Total Long-Term Liabilities $15.15M $15.11M
Total Liabilities $30.86M $30.09M
YoY Change -0.45% -21.44%
SHAREHOLDERS EQUITY
Retained Earnings -$243.6M -$241.5M
YoY Change 4.01% 3.57%
Common Stock $4.000K $4.000K
YoY Change -88.57% -88.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.343M $9.496M
YoY Change
Total Liabilities & Shareholders Equity $40.21M $39.58M
YoY Change -14.81% -28.3%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$2.122M -$99.00K
YoY Change 101.52% -96.86%
Depreciation, Depletion And Amortization $1.239M $1.250M
YoY Change -14.49% -12.46%
Cash From Operating Activities -$302.0K $591.0K
YoY Change -69.65% 237.71%
INVESTING ACTIVITIES
Capital Expenditures $62.00K $345.0K
YoY Change -92.49% -62.94%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$62.00K -$345.0K
YoY Change -92.49% -62.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.943M 0.000
YoY Change -1882.57% -100.0%
NET CHANGE
Cash From Operating Activities -302.0K 591.0K
Cash From Investing Activities -62.00K -345.0K
Cash From Financing Activities 1.943M 0.000
Net Change In Cash 1.579M 246.0K
YoY Change -181.81% -96.04%
FREE CASH FLOW
Cash From Operating Activities -$302.0K $591.0K
Capital Expenditures $62.00K $345.0K
Free Cash Flow -$364.0K $246.0K
YoY Change -80.01% -132.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3506025
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3506025
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3506025
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3506025
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
352000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.041
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001051514
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Cost Of Revenue
CostOfRevenue
7172000
us-gaap Cost Of Revenue
CostOfRevenue
7111000
us-gaap Gross Profit
GrossProfit
8017000
us-gaap Gross Profit
GrossProfit
8706000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
440000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
689000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6032000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7158000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4920000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5407000
us-gaap Costs And Expenses
CostsAndExpenses
11392000
us-gaap Costs And Expenses
CostsAndExpenses
13254000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3375000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4548000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-909000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1055000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
584000
us-gaap Investment Income Interest
InvestmentIncomeInterest
99000
us-gaap Investment Income Interest
InvestmentIncomeInterest
58000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
864000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1435000
us-gaap Net Income Loss
NetIncomeLoss
-3467000
us-gaap Net Income Loss
NetIncomeLoss
-5983000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.99
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3506025
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3506025
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3487119
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3487119
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12688000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
112000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3368000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
9432000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
163000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-99000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9496000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21831000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
325000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2835000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
19321000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
352000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
384000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3148000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16909000
sskn Deferred Financing Costs In Accounts Payable
DeferredFinancingCostsInAccountsPayable
0
sskn Deferred Financing Costs In Accounts Payable
DeferredFinancingCostsInAccountsPayable
62000
sskn Standard Product Warranty Term
StandardProductWarrantyTerm
P2Y
sskn Extended Product Warranty Term
ExtendedProductWarrantyTerm
P4Y
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
278000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
229000
CY2024Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
76000
CY2023Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
93000
CY2024Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
61000
CY2023Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
53000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
293000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
269000
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
182000
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
163000
CY2024Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
111000
CY2023Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
106000
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
303000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
207000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
115000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
120000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
125000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
58000
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
293000
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
269000
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
182000
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
163000
CY2024Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
111000
CY2023Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
106000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
611201
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
628921
CY2024Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P36M
CY2024Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P1Y
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
587000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
226000
CY2024Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q2 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
226000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
361000
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
78000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
104000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
154000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
236000
CY2024Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2363000
CY2023Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2192000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
329000
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
481000
CY2024Q2 us-gaap Inventory Net
InventoryNet
2692000
CY2023Q4 us-gaap Inventory Net
InventoryNet
2673000
us-gaap Inventory Write Down
InventoryWriteDown
141000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36466000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36062000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25317000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24284000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11149000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11778000
CY2024Q2 us-gaap Depreciation
Depreciation
759000
CY2023Q2 us-gaap Depreciation
Depreciation
713000
us-gaap Depreciation
Depreciation
1514000
us-gaap Depreciation
Depreciation
1390000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24222000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17888000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6334000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24222000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16903000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7319000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
491000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
715000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
985000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1435000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2024Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
986000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1266000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
561000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
561000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
561000
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
182000
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
180000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1974000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1679000
CY2024Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4304000
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4316000
CY2024Q2 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
148000
CY2023Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
131000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6608000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6306000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3750000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
7500000
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3750000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
15000000
CY2024Q2 sskn Debt Instrument Exit Fee
DebtInstrumentExitFee
600000
CY2024Q2 sskn Long Term Debt After Exit Fee
LongTermDebtAfterExitFee
15600000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
486000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
15114000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
275000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
677000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.77
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8435000
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
3498000
CY2024Q2 us-gaap Gross Profit
GrossProfit
4937000
CY2024Q2 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.585
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
199000
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3014000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2210000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
5423000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-486000
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
531000
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
54000
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
864000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-99000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15189000
us-gaap Cost Of Revenue
CostOfRevenue
7172000
us-gaap Gross Profit
GrossProfit
8017000
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.528
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
440000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6032000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4920000
us-gaap Costs And Expenses
CostsAndExpenses
11392000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3375000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1055000
us-gaap Investment Income Interest
InvestmentIncomeInterest
99000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
864000
us-gaap Net Income Loss
NetIncomeLoss
-3467000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8250000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3932000
CY2023Q2 us-gaap Gross Profit
GrossProfit
4318000
CY2023Q2 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.523
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
374000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3416000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2490000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
6280000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1962000
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-909000
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
298000
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
21000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3148000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15817000
us-gaap Cost Of Revenue
CostOfRevenue
7111000
us-gaap Gross Profit
GrossProfit
8706000
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.55
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
689000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7158000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5407000
us-gaap Costs And Expenses
CostsAndExpenses
13254000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4548000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-909000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
584000
us-gaap Investment Income Interest
InvestmentIncomeInterest
58000
us-gaap Net Income Loss
NetIncomeLoss
-5983000
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1250000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1428000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2499000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2825000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8435000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15189000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8250000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15817000
CY2024Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2024Q2 sskn Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease
ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease
977000
sskn Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease
ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease
0
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
122000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
123000
us-gaap Operating Lease Cost
OperatingLeaseCost
228000
us-gaap Operating Lease Cost
OperatingLeaseCost
229000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
112000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
109000
us-gaap Operating Lease Payments
OperatingLeasePayments
224000
us-gaap Operating Lease Payments
OperatingLeasePayments
205000
sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.1201
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y6M
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
229000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
463000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
334000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
290000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
301000
CY2024Q2 sskn Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
231000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1848000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
452000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1396000
sskn Development Agreement Term
DevelopmentAgreementTerm
P3Y
CY2023Q1 sskn Litigation Settlement To Be Paid
LitigationSettlementToBePaid
106000
CY2024Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
106000
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
106000
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
106000
CY2023Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
106000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001140361-24-037362-index-headers.html Edgar Link pending
0001140361-24-037362-index.html Edgar Link pending
0001140361-24-037362.txt Edgar Link pending
0001140361-24-037362-xbrl.zip Edgar Link pending
ef20030066_10q.htm Edgar Link pending
ef20030066_ex31-1.htm Edgar Link pending
ef20030066_ex31-2.htm Edgar Link pending
ef20030066_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
ef20030066_10q_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20240630.xsd Edgar Link pending
sskn-20240630_cal.xml Edgar Link unprocessable
sskn-20240630_def.xml Edgar Link unprocessable
sskn-20240630_lab.xml Edgar Link unprocessable
sskn-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable